Stem Cell Transplantation for Patients With Multiple Myeloma



Status:Recruiting
Conditions:Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:21 - 70
Updated:4/17/2018
Start Date:July 12, 2011
End Date:March 2019
Contact:Michael Bishop, MD
Email:mrbishop@uchicago.edu

Use our guide to learn which trials are right for you!

Pilot Study T Cell Depletion in the Setting of Autologous Stem Cell Transplantation for Patients With Multiple Myeloma

The purpose of this study is to test whether regulatory T-cell reduction is possible and safe
in myeloma subjects undergoing autologous stem cell transplantation (ASCT).


Inclusion Criteria:

- Symptomatic multiple myeloma of any subtype in any disease stage, providing that
patient does not have smoldering myeloma.

- Patient must otherwise be a candidate for ASCT as determined by treating physician.

- No current CNS Myeloma at time of enrollment.

- Life expectancy greater than 12 weeks.

- Age greater than or equal to 21 and less than or equal to 70 years old.

- EGOG performance status less than or equal to 2.

- No cardiac, pulmonary, hepatic, or renal contraindications for high dose chemotherapy.

- HIV Negative.

- No active Hepatitis B or C.

- Patients must be able to provide written informed, consent.

Exclusion Criteria:

- Pregnant or nursing women. Women of child-bearing age must be tested for pregnancy.

- Use of systemic immunosuppressive medications, including corticosteroids, tacrolimus,
mycophenolate mofetil, sirolimus or cyclosporine A.

- Psychiatric illness which may make compliance to the clinical protocol unmanageable or
which may compromise the ability of the patient to give informed consent.

- Active autoimmune disease including but not limited to: rheumatoid arthritis
inflammatory bowel disease, celiac disease, systemic lupus erythematosis, scleroderma
or multiple sclerosis.
We found this trial at
1
site
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials